2-D GEL
AML PATIENT
AML/ALL DISTINCTION
ANN
ANN
ANN
ANN
ALIZADEH STUDY
ALON
B-CELL LYMPHOMA
BMP6 EXPRESSION
COX
COX HAZARD ANALYSIS
PROPORTIONAL HAZARD COX
DIFFUSE LARGE B CELL LYMPHOMA
DLBCL LYMPHOMA
DLBCL PATIENT
DLBCL PATIENT
DLBCL PATIENT
DEHANASEKARAN
DETERMINING PATIENT PROGNOSIS
DHANASEKARAN
DIAGNOSING LYMPHOMA
ENHANCED IDENTIFICATION
CELL-TYPE ENHANCED IDENTIFICATION
FL PATIENT
INVESTIGATOR
K-NEAREST NEIGHBOR ANALYSIS
KAPLAN MEIER ANALYSIS
KAPLAN MEIER ESTIMATE
MH
NEURAL NET ANALYSIS
NEURAL NET ANALYSIS
NEURAL NETWORK
NEURAL NETWORK
NEURALWORK
NEW NETWORK
OCI LY1
PC
PEROU
PRECISE CLASSIFICATION
PRINCIPLE COMPONENT ANALYSIS
PROGNOSTIC INDEX
RMS ERROR
SOM CLASS
SVM
SUBSEQUENT ANALYSIS
SUBSEQUENT NETWORK
SUPPORT VECTOR MACHINE
T CELL
ACCURACY
ACCURACY
ACCURACY
ACCURACY
ACTIVATED B CELL-LIKE GROUP
ACTIVATED B CELL-LIKE GROUP
ACTIVATED B CELL-LIKE TUMOR
ACTIVATION
ARTIFICIAL NETWORK
ASSOCIATED GENE PROFILE
ATTEMPT RESULT
AUTOIMMUNE DISEASE
BACKPROPAGATION NETWORK
BACKPROPAGATION NEURAL NETWORK
BINARY REPRESENTATION
BIOLOGICAL ANALYSIS
BIOLOGICAL CHARACTERISTIC
BIOPSY
BLUE-CELL TUMOR
BRIEF DISCUSSION
CANCER PATIENT
CANCER STUDY
CANDIDATE MOLECULE
CELL-TYPE
CHANCE LEVEL
CLASS ASSIGNMENT
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION
CLASSIFICATION ACCURACY
CLASSIFICATION PROBLEM
CLASSIFICATION PROBLEM
CLASSIFICATION
CLASSIFICATION
CLASSIFYING BREAST TUMOR
CLINICAL OUTCOME
CLUSTERING RESULT
CLUSTERING RESULT
CLUSTERING TECHNIQUE
CONTROL STATE
CORRELATION COEFFICIENT
CORRESPONDING DATA SET
CURED/FATAL CLASS
CUTOFF
CUTOFF CRITERION
DERIVATIVE
DESIRED INFORMATION
DESIRED OUTCOME
DIAGNOSIS NETWORK
DIAGNOSTIC ACCURACY
DIAGNOSTIC ACCURACY
DIAGNOSTIC ACCURACY
DIAGNOSTIC ACCURACY
DIAGNOSTIC NETWORK
DIAGNOSTIC PURPOSE
DIFFERENTIATED EXAMPLE
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION
DIFFERENTIATION PROCESS
DIFFERENTIATION
DISCUSSING RISK GROUP
DOING CLUSTER ANALYSIS
DONOR POOL
DONOR PROFILE
DONOR PROFILE
DONOR SET
DONOR TYPE
EFFICACIOUS APPROACH
LIMITING TUMOR GROWTH EFFICACIOUS APPROACH
EMPLOYED NETWORK
ERROR LEVEL
ERROR LEVEL
ERROR-FREE PREDICTION
EXCLUSIVE
EXCLUSIVE
EXPERIMENTAL CONDITION
EXPRESSION LEVEL
EXPRESSION LEVEL
EXPRESSION LEVEL
FINAL SUBSET
FIND CORRELATION
FINE STRUCTURE ANALYSIS
FIXED
FOCUSED SIGHT
FOLLICULAR LYMPHOMA PATIENT
FOLLOW-UP DATA
FOLLOW-UP DONOR
FOLLOW-UP GROUP
FOLLOW-UP STUDY
FOLLOW-UP STUDY
FRACTION
GENE CLUSTER GROUP
GENE CLUSTER
GENE EXPRESSION
GENE EXPRESSION DATA
GENE EXPRESSION LEVEL
GENE EXPRESSION PANEL
GENE INPUT
GENE LIST
GENE PANEL
GENE PANEL NETWORK
GENE POOL
GENE PREDICTOR
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE SET
GENE STAGING SET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENE SUBSET
GENERAL PATIENT POPULATION
GENERAL POPULATION
POTENTIAL EXAMPLE GENERAL POPULATION
GENERALIZED DELTA LEARNING RULE
GERMINAL CENTER B CELL-LIKE TUMOR
IDENTIFICATION
IDENTIFICATION
IMMUNOHISTOCHEMICAL
IMMUNOTHERAPY
IMPROVED PERFORMANCE
IMPROVED RESULT
INCLUDING DATA
INCREASED ERROR
INCREASED TEST ERROR
INDEPENDENT TEST
INDEPENDENT TEST
INDIVIDUAL BASIS
INDIVIDUAL SCORE
INFLUENTIAL GENE
INFLUENTIAL INPUT
INFORMATION REDUNDANCY
INFORMATIVE GENE MARKER
INFORMATIVE SUBSET
INLIER
INPUT BIT
INPUT DATA
INPUT DATA
INPUT DATA EXAMPLE
INPUT DATUM
INPUT EXAMPLE
INPUT EXAMPLE
INPUT EXAMPLE
INPUT NEURON
INPUT NEURON
INPUT NEURON
INPUT NEURON
INPUT NEURON
INPUT SIZE
INPUT SPACE
INPUT VECTOR
INPUT VECTOR
NEURAL NETWORK INPUT VECTOR
KNOW
LIMITING TUMOR GROWTH
LYMPHOBLASTIC LEUKEMIA
LYMPHOMA
MAJORITY POLL
MAJORITY VOTE
MASS-SPEC DATA
MATCH CLUSTER ANALYSIS
MATCHING INPUT
MAXIMUM CONTRIBUTION
METASTATIC DISEASE
METASTATIC TUMOR
MICROARRAY
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA
MICROARRAY DATA CLUSTER ANALYSIS
MICROARRAY DATA CHIP
MICROARRAY EXPERIMENT
MICROARRAY STUDY
MICROARRAY
MIDDLE LAYER NEURON
MIDDLE-LAYER NEURON
MIDDLE-LAYER NEURON
MIDDLE-LAYER NEURON
MIDDLE-LAYER NEURON
MIDDLE-LAYER NEURON
MODEL INFORMATION
MOMENTUM COEFFICIENT
MORPHOLOGIC
MULTIPLE OUTPUT VALUE
MYELOID LEUKEMIA
NAIVE INTUITION
NEAR-PERFECT CLASSIFICATION
NEAR-PERFECT DIAGNOSIS
NEGATIVE DONOR
NEGATIVE LEVEL
NEIGHBOR ANALYSIS
NETWORK ROUND-ROBIN SERIES
NEURAL NET
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK SOFTWARE
NEURAL NETWORK STRATEGY
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURAL NETWORK
NEURON
NODE
NOISE LEVEL
NON-LINEARITY
NON-RESPONDER
NON-RESPONDER
NON-RESPONSIVE
NON-SPECIFIC SIMILARITY
NON-SURVIVAL
NON-SURVIVOR
NON-SURVIVOR
NON-SURVIVOR
NON-SURVIVOR
NON-TUMOROUS
NOVEL TUMOR REJECTION ANTIGEN
NUMEROUS RECENT CANCER STUDY
OBSERVED ERROR
ONE-MAN-OUT TEST
OPTIMUM OUTCOME CLASSIFICATION
ORIGINAL SET
OUTPUT
OUTPUT
OUTPUT
OUTPUT
OUTPUT ERROR CUTOFF
OUTPUT NEURON
OUTPUT NEURON
OUTPUT POINT
OUTPUT VALUE
OVER-TRAINING
OVERTRAINING
OVERTRAINING
OVERTRAINING
OVERVIEW
PAIRWISE SIMILARITY
PANEL NETWORK
PHENOTYPE
POSITIVE DONOR
POSITIVE DONOR
POSITIVE DONOR
POSSIBLE DISADVANTAGE
NEURAL NETWORK POSSIBLE DISADVANTAGE
POTENTIAL EXAMPLE
POTENTIAL TARGET ANTIGEN
PREDICTED OUTCOME
PREDICTIVE
PREPARATION
DIFFERENTIATION PREPARATION
PREPROCESSING
PRIMARY TOOL
PRODUCED GENE SUBSET
PROGNOSIS ACCURACY
PROGNOSIS ACCURACY
PROGNOSIS CLASSIFICATION ACCURACY
PROGNOSTIC NETWORK
PROGNOSTIC OUTCOME
PROPAGATION NETWORK
PROPORTIONAL HAZARD
PROSPECTIVE INFORMATION
PROSTATE BIOPSY SAMPLE
QUALIFIED SENSE
QUALITATIVE INFORMATION
QUALITATIVE NETWORK
QUALITATIVE NETWORK
QUANTITATIVE ASSESSMENT
QUANTITATIVE DEGREE
QUARTILE
RADIATION THERAPY
RECLUSTERING
REDUCED GENE PANEL
REDUCED GENE SET
REFERENCED
RELATIVE DEPENDENCE
OUTPUT RELATIVE DEPENDENCE
RELATIVE IMPACT
REPRESENTATIVE
GENERAL PATIENT POPULATION REPRESENTATIVE
REQUIRING AGREEMENT
RESERVE PATIENT
RESPONDER
RESPONDER
RETEST
RISK GROUP
RISK GROUP
RISK GROUP
RISK GROUP
RISK/LOW RISK GROUP
ROUND-ROBIN
ROUND-ROBIN FASHION
ROUND-ROBIN SERIES
ROUND-ROBIN TRAINING
SELECTED GENE
SELECTIVE CRITERION
SEMI-QUANTITATIVE ASSESSMENT
SIGMOID TRANSFER FUNCTION
SIGNATURE GENE GROUPING
SIGNATURE GENE
SIMILARITY
SIMILARITY
SIMPLIFIED INPUT
SINGLE DIFFERENTIATION
SINGLE ERROR
SINGLE ERROR
SINGLE GENE EXPRESSION TIME POINT
SINGLE NETWORK
SINGLE OUTPUT NEURON
SOFTWARE PROGRAM
SOLUTION
SOLUTION
SOLUTION
SPREADSHEET FORM
STANDARD SIGMOIDAL TRANSFER FUNCTION
STATISTICAL CORRELATION
STATISTICAL METHOD
STEP FUNCTION
SUBCATEGORY
SUBSELECTION
SUBSELECTION CHOICE
SUBSELECTION PROCESS
SUBSET
SUBSET
SUBSET
SUBSET
SUBSET
SUBSET
SUBSET DETERMINATION
SUBSET
SUBSET
SUPERSET
SUPERVISED LEARNING METHOD
SUPERVISED STEP
SUPERVISED STEP
SURVIVAL ACCURACY
SURVIVAL CATEGORY
SURVIVAL CLASSIFICATION
SURVIVAL DATA
SURVIVAL OUTCOME
SURVIVAL PATTERN
SURVIVAL PREDICTION
SURVIVAL PREDICTION
SURVIVAL PROBABILITY PLOT
SURVIVAL RATE
SURVIVAL RATE
TARGET ANTIGEN
TARGET ORGAN
TASKED
TEST DATA
TEST DATA
TEST DATA
TEST DATA
TEST DONOR
TEST INPUT EXAMPLE
TEST MODE
TEST PATIENT
TEST RESULT
TEST SCORE
TEST SET
TEST SET
TEST SET
TEST SET
TEST SET
TEST SET
TEST SET
TEST SET
TEST SET
TEST VECTOR
TEST VECTOR
TESTING PURPOSE
THREE-LAYER
TOLERANCE INDUCTION
TRAINED NETWORK
TRAINED NETWORK
TRAINED NETWORK
TRAINED NETWORK
TRAINED NETWORK
TRAINING EXAMPLE
TRAINING EXAMPLE
TRAINING ITERATION
TRAINING SESSION
TRAINING SESSION
TRAINING SET
TRAINING SET
TRAINING SET
TRAINING SET
TRAINING SET
TRAINING SET
TRAINING SET
TRAINING SET
TRAINING TIME
TRAINING/TESTING
TUMOR
TUMOR
TUMOR
TUMOR
TUMOR REJECTION ANTIGEN
TYROSINE KINASE RECEPTOR GENE
UNDERGOING CHEMOTHERAPY
UNDERLYING FIGURE
UNDESIRABLE EFFECT
UNKNOWN
USE ARRAY DATA
USE SELF-ORGANIZING-MAP
VAN'T
VIEWPOINT
WEIGHT MATRIX
WEIGHTED COMBINATION
INFORMATIVE GENE MARKER WEIGHTED COMBINATION
WEIGHTED CONNECTION
WORK FLOW
WORK FLOW
YEAR PROGNOSIS
YR
YR
YR
YR
YR
YR
YR
DIFFUSE LARGE B-CELL LYMPHOMA
DLBCL
ACUTE MYELOID LEUKEMIA
AML
ACUTE         LYMPHOBLASTIC LEUKEMIA
ALL
SELF-ORGANIZING-MAPS
SOM
distinctions
studies
LYMPHOMA
expressions
HAZARD ANALYSIS
LYMPHOMA
LYMPHOMA
IDENTIFICATION
NEIGHBOR ANALYSIS
MEIER ANALYSIS
NEURAL NET
NET ANALYSIS
NEURAL NET
NET ANALYSIS
LY1
CLASSIFICATION
COMPONENT ANALYSIS
INDEX
errors
analyses
VECTOR MACHINE
B
B
B
associated genes
gene profile
attempts
results
BACKPROPAGATION
representation
discussions
candidates
CHANCE
classes
assignments
CLASSIFICATION
CLASSIFICATION
problems
CLASSIFICATION
outcomes
results
results
controls
correlations
CURED/FATAL
CUTOFF
INFORMATION
outcomes
DIAGNOSIS
DIFFERENTIATION
DISCUSSING RISK
CLUSTER ANALYSIS
donors
donors
donors
donors
donors
errors
errors
expressions
expressions
expressions
SUBSET
FIND
STRUCTURE ANALYSIS
SIGHT
FOLLICULAR LYMPHOMA
LYMPHOMA
FOLLOW-UP
FOLLOW-UP
FOLLOW-UP
FOLLOW-UP
studies
FOLLOW-UP
studies
genes
genes
genes
expressions
GENE EXPRESSION
genes
GENE EXPRESSION
genes
GENE EXPRESSION
genes
genes
genes
genes
genes
genes
genes
PREDICTOR
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
genes
SUBSET
genes
SUBSET
genes
SUBSET
genes
SUBSET
genes
genes
genes
genes
genes
GENERAL
patient populations
GENERAL
populations
DELTA LEARNING RULE
learning rule
B
PERFORMANCE
results
errors
test error
tests
tests
BASIS
genes
INFORMATION
INFORMATIVE GENE
SUBSET
inputs
inputs
inputs
inputs
inputs
datum
inputs
inputs
inputs
inputs
NEURON
inputs
NEURON
inputs
inputs
inputs
inputs
inputs
inputs
inputs
tumor growth
POLL
VOTE
matches
CLUSTER ANALYSIS
inputs
maximum
contribution
METASTATIC
METASTATIC
MICROARRAY
MICROARRAY
MICROARRAY
MICROARRAY
MICROARRAY
MICROARRAY
MICROARRAY
MICROARRAY
MICROARRAY
DATA CLUSTER ANALYSIS
CLUSTER ANALYSIS
MICROARRAY
MICROARRAY
MICROARRAY
studies
MIDDLE LAYER
INFORMATION
MULTIPLE OUTPUT
INTUITION
CLASSIFICATION
DIAGNOSIS
donors
neighbors
analyses
NEURAL NETWORK
NEURAL NETWORK
noise
non-specific
NOVEL TUMOR REJECTION
errors
tests
OUTCOME CLASSIFICATION
OUTPUT
ERROR CUTOFF
OUTPUT
NEURON
OUTPUT
NEURON
OUTPUT
OUTPUT
SIMILARITY
donors
disadvantages
POTENTIAL TARGET
outcomes
PRIMARY
produced gene
outcomes
PROPAGATION
INFORMATION
PROSTATE BIOPSY
BIOPSY
SENSE
INFORMATION
assessments
degrees
radiation
therapies
REDUCED GENE
REDUCED GENE
DEPENDENCE
IMPACT
AGREEMENT
RISK
RISK
RISK
RISK
RISK/LOW RISK
FASHION
assessments
SIGMOID
TRANSFER FUNCTION
SIGNATURE GENE
signatures
signatures
inputs
SINGLE
DIFFERENTIATION
SINGLE
errors
SINGLE
errors
SINGLE
SINGLE
SINGLE
OUTPUT NEURON
standards
sigmoidal transfer function
TRANSFER FUNCTION
steps
functions
SUBSELECTION
SUBSELECTION
SUBSET
determination
steps
steps
SURVIVAL
SURVIVAL
SURVIVAL
CLASSIFICATION
SURVIVAL
SURVIVAL
outcomes
SURVIVAL
SURVIVAL
SURVIVAL
SURVIVAL
SURVIVAL
SURVIVAL
targets
targets
tests
tests
tests
tests
tests
tests
INPUT EXAMPLE
tests
tests
tests
tests
tests
tests
tests
tests
tests
tests
tests
tests
tests
tests
tests
induction
examples
sessions
times
TUMOR REJECTION
tyrosine kinases
tyrosine
KINASE RECEPTOR GENE
receptor genes
kinase
receptors
FIGURE
effects
uses
uses
weights
combinations
works
FLOW
works
FLOW
